Medinotec (MDNC) Research & Development (2022 - 2026)
Medinotec (MDNC) posted Research & Development of $503255.0 for Q2 2026, up 12.46% on a QoQ basis from $447511.0 in Q1 2026, and up 926.76% year-over-year from $49014.0 in Q2 2025.
Medinotec (MDNC) Research & Development (2022 - 2026) Analysis & Trends
Medinotec's Research & Development history runs 5 years deep, the most recent figure standing at $503255.0 for Q2 2026.
- Quarterly Research & Development rose 926.76% year-over-year to $503255.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $1.4 million (up 1238.49% YoY) and the FY2026 annual result came in at $1.5 million, up 1530.19% from the prior year.
- Research & Development was $503255.0 for Q2 2026 at Medinotec, up from $447511.0 in the prior quarter.
- Across five years, Research & Development topped out at $503255.0 in Q2 2026 and bottomed at -$127222.0 in Q1 2023.
- A 5-year average of $66956.4 and a median of $14300.5 in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development tumbled 859.81% — and 2026, when it jumped 8866.36%.
- Medinotec's Research & Development stood at $21249.0 in 2022, then sank by 87.16% to $2728.0 in 2023, then soared by 1572.73% to $45632.0 in 2024, then soared by 649.37% to $341953.0 in 2025, then jumped by 47.17% to $503255.0 in 2026.
- Business Quant data shows MDNC's Research & Development at $503255.0 in Q2 2026, $447511.0 in Q1 2026, and $341953.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 503,255.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 503,255.00 |
| Feb 28, 2026 | 447,511.00 |
| Nov 30, 2025 | 341,953.00 |
| Aug 31, 2025 | 66,235.00 |
| May 31, 2025 | 49,014.00 |
| Feb 28, 2025 | 4,991.00 |
| Nov 30, 2024 | 45,632.00 |
| Aug 31, 2024 | 1,892.00 |
| May 31, 2024 | -21,008.00 |
| Feb 29, 2024 | -101,410.00 |
| Nov 30, 2023 | 2,728.00 |
| Aug 31, 2023 | 11,857.00 |
| May 31, 2023 | -46,039.00 |
| Feb 28, 2023 | -127,222.00 |
| Nov 30, 2022 | 21,249.00 |
| Aug 31, 2022 | 21,892.00 |
| May 31, 2022 | -34,058.00 |
| Feb 28, 2022 | 16,744.00 |